| [1] |
Martin SS, Aday AW, Allen NB, et al. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association[J]. Circulation, 2025, 151(8): e41-660. doi:10.1161/cir.0000000000001345
|
| [2] |
Xu YT, Wu SY, Zhang L, et al. Cell death forms in myocardial ischemia-reperfusion injury and their potential clinical applications[J]. Mol Cell Biochem, 2025, 481(2): 695-709. doi:10.1007/s11010-025-05440-7
|
| [3] |
Kato T, Lee RT. GDF-11 as a potential cardiac pro-angiogenic factor[J]. JACC Basic Transl Sci, 2023, 8(6): 636-7. doi:10.1016/j.jacbts.2023.04.003
|
| [4] |
Chen CY, Liu CC, Stavropoulos D, et al. The distinct roles of TGF-β signaling in retinal development[J]. iScience, 2025, 28(11): 113737. doi:10.1016/j.isci.2025.113737
|
| [5] |
Loffredo FS, Steinhauser ML, Jay SM, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy[J]. Cell, 2013, 153(4): 828-39. doi:10.1016/j.cell.2013.04.015
|
| [6] |
Katsimpardi L, Litterman NK, Schein PA, et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors[J]. Science, 2014, 344(6184): 630-4. doi:10.1126/science.1251141
|
| [7] |
Sinha M, Jang YC, Oh J, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle[J]. Science, 2014, 344(6184): 649-52. doi:10.1126/science.1251152
|
| [8] |
Su X, Chen LL, Qiu YH, et al. GDF11 regulates vascular smooth muscle cell phenotype switching to prevent aortic aneurysm formation[J]. Cardiovasc Drugs Ther, 2025: doi: 10.1007/s10557-025-07814-x . Online ahead of print.
|
| [9] |
Du GQ, Shao ZB, Wu J, et al. Targeted myocardial delivery of GDF11 gene rejuvenates the aged mouse heart and enhances myocardial regeneration after ischemia-reperfusion injury[J]. Basic Res Cardiol, 2017, 112(1): 7. doi:10.1007/s00395-016-0593-y
|
| [10] |
Olson KA, Beatty AL, Heidecker B, et al. Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts[J]. Eur Heart J, 2015, 36(48): 3426-34. doi:10.1093/eurheartj/ehv385
|
| [11] |
Liu Y, Qu Y, Wang RT, et al. The alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury[J]. Am J Physiol Endocrinol Metab, 2012, 303(7): E841-52. doi:10.1152/ajpendo.00075.2012
|
| [12] |
Jiao L, Shao YC, Yu Q, et al. GDF11 replenishment protects against hypoxia-mediated apoptosis in cardiomyocytes by regulating autophagy[J]. Eur J Pharmacol, 2020, 885: 173495. doi:10.1016/j.ejphar.2020.173495
|
| [13] |
Zhao D, Wang ZH, Chen YY, et al. GDF11 alleviates cardiac ischemia/reperfusion injury by suppressing the mtDNA damage-inflammatory response axis[J]. Eur J Pharmacol, 2025, 993: 177392. doi:10.1016/j.ejphar.2025.177392
|
| [14] |
Zhou RS, Xue XH, Bi Y, et al. Sevoflurane activates PI3K/AKT signaling pathway by upregulating GDF11 expression to attenuate ischemia/reperfusion injury in cardiomyocytes[J]. Discov Med, 2024, 36(189): 2071-8. doi:10.24976/discov.med.202436189.191
|
| [15] |
Kraler S, Balbi C, Vdovenko D, et al. Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans[J]. Cardiovasc Res, 2023, 119(17): 2729-42. doi:10.1093/cvr/cvad153
|
| [16] |
Yang Q, Wang HC, Liu Y, et al. Resveratrol cardioprotection against myocardial ischemia/reperfusion injury involves upregulation of adiponectin levels and multimerization in type 2 diabetic mice[J]. J Cardiovasc Pharmacol, 2016, 68(4): 304-12. doi:10.1097/fjc.0000000000000417
|
| [17] |
Liu Y, Zeng JR, Liu XY, et al. Growth differentiation factor 11 attenuates photoaging through ferroptosis pathway in SZ95 sebocytes[J]. Am J Pathol, 2025, 195(12): 2356-72. doi:10.1016/j.ajpath.2025.07.015
|
| [18] |
Ben Driss L, Lian J, Walker RG, et al. GDF11 and aging biology- controversies resolved and pending[J]. J Cardiovasc Aging, 2023, 3(4). DOI:10.20517/jca.2023.23 .
|
| [19] |
Wang ZH, Zhang YX, Liu W, et al. GDF11 alleviates spinal cord injury in rats by modulating microglia polarization through Smad2/3 and MAPK/NFκB signaling pathways[J]. Int Immunopharmacol, 2025, 163: 115197. doi:10.1016/j.intimp.2025.115197
|
| [20] |
Lian J, Walker RG, D'Amico A, et al. Functional substitutions of amino acids that differ between GDF11 and GDF8 impact skeletal development and skeletal muscle[J]. Life Sci Alliance, 2023, 6(3): e202201662. doi:10.26508/lsa.202201662
|
| [21] |
Kizer JR, Patel S, Ganz P, et al. Circulating growth differentiation factors 11 and 8, their antagonists follistatin and follistatin-like-3, and risk of heart failure in Elders[J]. J Gerontol A Biol Sci Med Sci, 2024, 79(1): glad206. doi:10.1093/gerona/glad206
|
| [22] |
Wang CZ, Liu XC, Hu XL, et al. Therapeutic targeting of GDF11 in muscle atrophy: Insights and strategies[J]. Int J Biol Macromol, 2024, 279(Pt 3): 135321. doi:10.1016/j.ijbiomac.2024.135321
|
| [23] |
Shao YC, Li MM, Wang YY, et al. GDF11 mitigates high glucose-induced cardiomyocytes apoptosis by inhibiting the ALKBH5-FOXO3 -CDR1as/Hippo signaling pathway[J]. Biochim Biophys Acta Mol Cell Res, 2024, 1871(3): 119656. doi:10.1016/j.bbamcr.2023.119656
|
| [24] |
Cohen OS, Sinha M, Wang YT, et al. Recombinant GDF11 promotes recovery in a rat permanent ischemia model of subacute stroke[J]. Stroke, 2025, 56(4): 996-1009. doi:10.1161/strokeaha.124.049908
|
| [25] |
Xing Y, Ma XY, Zhai RK, et al. GDF11 improves hippocampal neurogenesis and cognitive abilities in diabetic mice by reducing neural inflammation[J]. Brain Behav Immun, 2024, 120: 21-31. doi:10.1016/j.bbi.2024.05.024
|
| [26] |
Ruiz-Meana M, Bou-Teen D, Ferdinandy P, et al. Cardiomyocyte ageing and cardioprotection: consensus document from the ESC working groups cell biology of the heart and myocardial function[J]. Cardiovasc Res, 2020, 116(11): 1835-49. doi:10.1093/cvr/cvaa132
|
| [27] |
Zhu JY, Zhang N, Zhao Y, et al. Deficiency of GDF-11 accelerates TAC-induced heart failure by impairing cardiac angiogenesis[J]. JACC Basic Transl Sci, 2023, 8(6): 617-35. doi:10.1016/j.jacbts.2022.11.004
|
| [28] |
Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective[J]. Nat Rev Cardiol, 2020, 17(12): 773-89. doi:10.1038/s41569-020-0403-y
|
| [29] |
Chen L, Luo GJ, Liu YM, et al. Growth differentiation factor 11 attenuates cardiac ischemia reperfusion injury via enhancing mitochondrial biogenesis and telomerase activity[J]. Cell Death Dis, 2021, 12(7): 665. doi:10.1038/s41419-021-03954-8
|
| [30] |
Tao P, Zhang HF, Zhou P, et al. Growth differentiation factor 11 alleviates oxidative stress-induced senescence of endothelial progenitor cells via activating autophagy[J]. Stem Cell Res Ther, 2024, 15(1): 370. doi:10.1186/s13287-024-03975-y
|
| [31] |
Dou FF, Wu BL, Chen JL, et al. PPARα targeting GDF11 inhibits vascular endothelial cell senescence in an atherosclerosis model[J]. Oxid Med Cell Longev, 2021, 2021: 2045259. doi:10.1155/2021/2045259
|
| [32] |
Huang SS, Wu YL, Chen MY, et al. GDF11 improves cardiac repair after myocardial infarction by reducing Macrophage infiltration and attenuating their inflammatory Properties[J]. Int Immuno-pharmacol, 2025, 147: 113994. doi:10.1016/j.intimp.2024.113994
|
| [33] |
Wang L, Xu WY, Tang YW, et al. Nitrative inactivation of thioredoxin-1 loses its protective effect in bleomycin-induced pulmonary fibrosis[J]. Int Immunopharmacol, 2022, 112: 109208. doi:10.1016/j.intimp.2022.109208
|
| [34] |
Cao Q, Liu L, Hu YG, et al. Low-intensity pulsed ultrasound of different intensities differently affects myocardial ischemia/reperfusion injury by modulating cardiac oxidative stress and inflammatory reaction[J]. Front Immunol, 2023, 14: 1248056. doi:10.3389/fimmu.2023.1248056
|